Use of liposomal anthracyclines in Kaposi's sarcoma

Seminars in Oncology

Volumn 31, Issue SUPPL. 13, 2004, Pages 36-52

  Krown, Susan E ^a   Northfelt, Donald W ^b   Osoba, David ^c   Stewart, J Simon ^d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c QOL Consulting   (Canada)

^d IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTHRACYCLINE; ANTIRETROVIRUS AGENT; BLEOMYCIN; CHORIONIC GONADOTROPIN; COLONY STIMULATING FACTOR; DAUNORUBICIN; DIDANOSINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FUMAGILLOL CHLOROACETYLCARBAMATE; LIPOSOME; MATRIX METALLOPROTEINASE INHIBITOR; MITOXANTRONE; PACLITAXEL; PROTEINASE INHIBITOR; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RETINOID; SCLEROSING AGENT; SEMAXANIB; TAXANE DERIVATIVE; THALIDOMIDE; UNINDEXED DRUG; VINBLASTINE; VINCA ALKALOID; VINCRISTINE; ZIDOVUDINE;

ABDOMINAL PAIN; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARGON LASER; BACKACHE; BACTERIAL INFECTION; BONE MARROW TOXICITY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CELL PROLIFERATION; CLINICAL TRIAL; CRYOTHERAPY; DIARRHEA; DRUG APPROVAL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG UPTAKE; DYSPNEA; ENCAPSULATION; ERYTHEMA; FATIGUE; FEVER; FLU LIKE SYNDROME; FLUSHING; FOOD AND DRUG ADMINISTRATION; GRANULOCYTOPENIA; HAIR LOSS; HAND FOOT SYNDROME; HEADACHE; HEART FAILURE; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HYPERTENSION; HYPOTENSION; KAPOSI SARCOMA; LEUKOPENIA; LIVER DISEASE; LIVER TOXICITY; LUNG METASTASIS; LUNG TOXICITY; MUCOSA INFLAMMATION; NAUSEA; NAUSEA AND VOMITING; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; NONHUMAN; PATHOGENESIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; RIGOR; SIDE EFFECT; SKIN TOXICITY; STOMATITIS; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA;

EID: 11144301724     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.08.003     Document Type: Article

References (100)

1. C.Y. Wang, A.L. Schroeter, W.P. Su Acquired immunodeficiency syndrome-related Kaposi's sarcoma Mayo Clin Proc 70 1995 869 879
2. S.E. Krown Acquired immunodeficiency syndrome-associated Kaposi's sarcoma. Biology and management Med Clin North Am 81 1997 471 494
3. R.T. Mitsuyasu AIDS-related Kaposi's sarcoma Current treatment options, future trends Oncology (Huntingt) 14 2000 867 878
4. B.S. Peters, E.J. Beck, D.G. Coleman Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom The changing face of AIDS BMJ 302 1991 203 207
5. S.E. Krown Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma Implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma J Clin Oncol 22 2004 399 402
6. S.E. Krown Clinical overview issues in Kaposi's sarcoma therapeutics J Natl Cancer Inst Monogr 23 1998 59 63
7. C. Boshoff, R.A. Weiss Kaposi's sarcoma-associated herpesvirus Adv Cancer Res 75 1998 57 86
8. J. Iscovich, P. Boffetta, S. Franceschi Classic Kaposi sarcoma Epidemiology and risk factors Cancer 88 2000 500 517
9. R.F. Little, J.M. Pluda, E. Feigal The challenge of designing clinical trials for AIDS-related Kaposi's sarcoma Oncology (Huntingt) 12 1998 871 877
10. S.E. Krown, C. Metroka, J.C. Wernz Kaposi's sarcoma in the acquired immune deficiency syndrome A proposal for uniform evaluation, response, and staging criteria AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 7 1989 1201 1207
11. S.E. Krown, M.A. Testa, J. Huang AIDS-related Kaposi's sarcoma Prospective validation of the AIDS Clinical Trials Group staging classification AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 15 1997 3085 3092
12. K.M. Hebeda, M.T. Huizing, P.A. Brouwer Photodynamic therapy in AIDS-related cutaneous Kaposi's sarcoma J Acquir Immune Defic Syndr Hum Retrovirol 10 1995 61 70
13. Z.P. Bernstein, B.D. Wilson, A.R. Oseroff Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma Aids 13 1999 1697 1704
14. Panretin (alitretinoin, topical gel 0.1%) prescribing information 2001 Ligand Pharmaceuticals Incorporated San Diego, CA
15. S. Walmsley, D.W. Northfelt, B. Melosky Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group J Acquir Immune Defic Syndr 22 1999 235 246
16. M. Duvic, A.E. Friedman-Kien, D.J. Looney Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel Results of phase 1 and 2 trials Arch Dermatol 136 2000 1461 1469
17. S.E. Krown, F.X. Real, S. Cunningham-Rundles Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma N Engl J Med 308 1983 1071 1076
18. F.X. Real, H.F. Oettgen, S.E. Krown Kaposi's sarcoma and the acquired immunodeficiency syndrome Treatment with high and low doses of recombinant leukocyte A interferon J Clin Oncol 4 1986 544 551
19. L.M. Evans, L.M. Itri, M. Campion Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma J Immunother 10 1991 39 50
20. R. de Wit, J.K. Schattenkerk, C.A. Boucher Clinical and virological effects of high-dose recombinant interferon-alpha in disseminated AIDS-related Kaposi's sarcoma Lancet 2 1988 1214 1217
21. Intron A (Interferon alfa-2b, recombinant for injection) prescribing information 2002 Schering-Plough Corp Kenilworth, NJ
22. Roferon A (interferon alfa-2a, recombinant) prescribing information 2003 Hoffman-LaRoche, Inc Nutley, NJ
23. P.S. Gill, B. Akil, P. Colletti Pulmonary Kaposi's sarcoma Clinical findings and results of therapy Am J Med 87 1989 57 61
24. P.S. Gill, M. Rarick, J.A. McCutchan Systemic treatment of AIDS-related Kaposi's sarcoma Results of a randomized trial Am J Med 90 1991 427 433
25. M.A. Fischl, S.E. Krown, K.P. O'Boyle Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group J Acquir Immune Defic Syndr 6 1993 259 264
26. F.A. Shepherd, R.L. Burkes, K.E. Paul A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS AIDS 5 1991 305 309
27. L. Kaplan, P.A. Volberding Failure (and danger) of mitozantrone in AIDS-related Kaposi's sarcoma Lancet 2 1985 396
28. K. Lassoued, J.P. Clauvel, C. Katlama Treatment of the acquired immune deficiency syndrome-related Kaposi's sarcoma with bleomycin as a single agent Cancer 66 1990 1869 1872
29. S.C. Remick, M. Reddy, D. Herman Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma J Clin Oncol 12 1994 1130 1136
30. D.E. Hernandez, J.R. Perez Advanced epidemic Kaposi's sarcoma Treatment with bleomycin or combination of doxorubicin, bleomycin, and vincristine Int J Dermatol 35 1996 831 833
31. D.M. Mintzer, F.X. Real, L. Jovino Treatment of Kaposi's sarcoma and thrombocytopenia with vincristine in patients with the acquired immunodeficiency syndrome Ann Intern Med 102 1985 200 202
32. E. Rieber, A. Mittelman, G.P. Wormser Vincristine and Kaposi's sarcoma in the acquired immunodeficiency syndrome Ann Intern Med 101 1984 876
33. P.A. Volberding, D.I. Abrams, M. Conant Vinblastine therapy for Kaposi's sarcoma in the acquired immunodeficiency syndrome Ann Intern Med 103 1985 335 338
34. G. Nasti, D. Errante, R. Talamini Vinorelbine is an effective and safe drug for AIDS-related Kaposi's sarcoma Results of a phase II study J Clin Oncol 18 2000 1550 1557
35. L. Welles, M.W. Saville, J. Lietzau Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma J Clin Oncol 16 1998 1112 1121
36. P.S. Gill, A. Tulpule, B.M. Espina Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma J Clin Oncol 17 1999 1876 1883
37. L.J. Laubenstein, R.L. Krigel, C.M. Odajnyk Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine J Clin Oncol 2 1984 1115 1120
38. L. Brambilla, V. Boneschi, S. Fossati Oral etoposide for Kaposi's Mediterranean sarcoma Dermatologica 177 1988 365 369
39. G. Schwartsmann, E. Sprinz, M. Kromfield Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy J Clin Oncol 15 1997 2118 2124
40. S.C. Remick, M. Reddy, K. Ekman Continuous infusion etoposide in advanced AIDS-related Kaposi sarcoma J Infus Chemother 6 1996 92 96
41. E. Sprinz, A.P. Caldas, D.R. Mans Fractionated doses of oral etoposide in the treatment of patients with AIDS-related Kaposi sarcoma A clinical and pharmacologic study to improve therapeutic index Am J Clin Oncol 24 2001 177 184
42. J. Paredes, J.O. Kahn, W.P. Tong Weekly oral etoposide in patients with Kaposi's sarcoma associated with human immunodeficiency virus infection A phase I multicenter trial of the AIDS Clinical Trials Group J Acquir Immune Defic Syndr Hum Retrovirol 9 1995 138 144
43. G. Schwartsmann, E. Sprinz, M. Kronfeld Phase II study of teniposide in patients with AIDS-related Kaposi's sarcoma Eur J Cancer 27 1991 1637 1639
44. R.F. Little, K.M. Wyvill, J.M. Pluda Activity of thalidomide in AIDS-related Kaposi's sarcoma J Clin Oncol 18 2000 2593 2602
45. K. Fife, M.R. Howard, F. Gracie Activity of thalidomide in AIDS-related Kaposi's sarcoma and correlation with HHV8 titre Int J STD AIDS 9 1998 751 755
46. S.E. Krown, J.W. Gold, D. Niedzwiecki Interferon-alpha with zidovudine Safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 112 1990 812 821
47. J.A. Kovacs, L. Deyton, R. Davey Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS) Ann Intern Med 111 1989 280 287
48. M.A. Fischl, R.B. Uttamchandani, L. Resnick A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma J Acquir Immune Defic Syndr 4 1991 1 10
49. M.A. Fischl, D.M. Finkelstein, W. He A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group J Acquir Immune Defic Syndr Hum Retrovirol 11 1996 379 384
50. S.E. Krown, P. Li, J.H. Von Roenn Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma A randomized phase II AIDS clinical trials group study J Interferon Cytokine Res 22 2002 295 303
51. M. Puoti, B. Zanini, R. Bruno Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV HIV Clin Trials 3 2002 324 332
52. M.E. McGarvey, A. Tulpule, J. Cai Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma Curr Opin Oncol 10 1998 413 421
53. P.E. Stoebner, T. Nocera, J. Meynadier Efficacy of docetaxel in disseminated classical Kaposi's sarcoma Br J Dermatol 143 2000 1357 1359
54. R. Yarchoan Therapy for Kaposi's sarcoma Recent advances and experimental approaches J Acquir Immune Defic Syndr 21 suppl 1 1999 S66 S73
55. P. Gill, M. Rarick, M. Bernstein-Singer Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine Am J Clin Oncol 13 1990 315 319
56. P.S. Gill, S.A. Miles, R.T. Mitsuyasu Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma Aids 8 1994 1695 1699
57. P.S. Gill, R.T. Mitsuyasu, T. Montgomery AIDS Clinical Trials Group Study 094 A phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma Cancer J Sci Am 3 1997 278 283
58. A. Mastroianni, O. Coronado, C. Cancellieri Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor J Chemother 10 1998 405 410
59. P.J. Bakker, S.A. Danner, C.H. ten Napel Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF) Eur J Cancer 31A 1995 188 192
60. M. Tavio, E. Vaccher, A. Antinori Combination chemotherapy with doxorubicin, bleomycin, and vindesine for AIDS-related Kaposi's sarcoma Cancer 77 1996 2117 2122
61. M.U. Rarick, P.S. Gill, T. Montgomery Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine Ann Oncol 1 1990 147 149
62. M.M. Gompels, A. Hill, P. Jenkins Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin AIDS 6 1992 1175 1180
63. E.P. Gelmann, D. Longo, H.C. Lane Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome Am J Med 82 1987 456 462
64. E. Sloand, P.N. Kumar, P.F. Pierce Chemotherapy for patients with pulmonary Kaposi's sarcoma Benefit of filgrastim (G-CSF) in supporting dose administration South Med J 86 1993 1219 1224
65. Doxil (doxorubicin HCl liposome injection) prescribing information 2001 Ortho Biotech Products, LP Bridgewater, NJ
66. T.W. Cheung, S.C. Remick, N. Azarnia AIDS-related Kaposi's sarcoma: A phase II study of liposomal doxorubicin. The TLC D-99 Study Group Clin Cancer Res 5 1999 3432 3437
67. T.M. Allen, F.J. Martin Advantages of liposomal delivery systems for anthracyclines Semin Oncol 31 suppl 13 2004 5 15
68. D.M. Logan, L.G. Filion, R. Gaudreault The effect of daunorubicin (Dauno) or doxorubicin (Doxo) on epidemic Kaposi's sarcoma (EKS) derived cell cultures Int Conf AIDS 7 1991 99 (abstr WA 1030)
69. M. Sturzl, C. Zietz, B. Eisenburg Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma Clinical, histological and cell biological evaluation Res Virol 145 1994 261 269
70. S.K. Huang, F.J. Martin, G. Jay Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene Am J Pathol 143 1993 10 14
71. J. Vogel, S.H. Hinrichs, R.K. Reynolds The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice Nature 335 1988 606 611
72. D.M. Vail, M.A. Amantea, G.T. Colbern Pegylated liposomal doxorubicin Proof of principle using preclinical animal models and pharmacokinetic studies Semin Oncol 31 suppl 13 2004 16 35
73. D.W. Northfelt, F.J. Martin, P. Working Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol Pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma J Clin Pharmacol 36 1996 55 63
74. D.W. Northfelt, L. Kaplan, J. Russell Pharmacokinetics and tumor localization of DOX-SL (Stealth liposomal doxorubicin) by comparison with Adriamycin in patients with AIDS and Kaposi's sarcoma D.D. Lasic F.J. Martin Stealth Liposomes 1995 CRC Press Boca Raton, FL 257 266
75. U.R. Hengge, N.H. Brockmeyer, M. Baumann Liposomal doxorubicin in AIDS-related Kaposi's sarcoma Lancet 342 1993 497
76. J.K. Simpson, R.F. Miller, M.F. Spittle Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma Clin Oncol (R Coll Radiol) 5 1993 372 374
77. J.R. Bogner, U. Kronawitter, B. Rolinski Liposomal doxorubicin in the treatment of advanced AIDS-related Kaposi sarcoma J Acquir Immune Defic Syndr 7 1994 463 468
78. N.D. James, R.J. Coker, D. Tomlinson Liposomal doxorubicin (Doxil) An effective new treatment for Kaposi's sarcoma in AIDS Clin Oncol (R Coll Radiol) 6 1994 294 296
79. D. Wagner, W.V. Kern, P. Kern Liposomal doxorubicin in AIDS-related Kaposi's sarcoma Long-term experiences Clin Investig 72 1994 417 423
80. C. Bergin, A. O'Leary, C. McCreary Treatment of Kaposi's sarcoma with liposomal doxorubicin Am J Health Syst Pharm 52 1995 2001 2004
81. M. Harrison, D. Tomlinson, S. Stewart Liposomal-entrapped doxorubicin An active agent in AIDS-related Kaposi's sarcoma J Clin Oncol 13 1995 914 920
82. F.D. Goebel, D. Goldstein, M. Goos Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group Br J Cancer 73 1996 989 994
83. D.W. Northfelt, B.J. Dezube, J.A. Thommes Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy J Clin Oncol 15 1997 653 659
84. M. Grunaug, J.R. Bogner, O. Loch Liposomal doxorubicin in pulmonary Kaposi's sarcoma Improved survival as compared to patients without liposomal doxorubicin Eur J Med Res 3 1998 13 19
85. M. Newell, S. Milliken, D. Goldstein A phase II study of liposomal doxorubicin in the treatment of HIV-related Kaposi's sarcoma Aust N Z J Med 28 1998 777 783
86. U.R. Hengge, S. Esser, H.P. Rudel Long-term chemotherapy of HIV-associated Kaposi's sarcoma with liposomal doxorubicin Eur J Cancer 37 2001 878 883
87. M. Nunez, P. Saballs, M.E. Valencia Response to liposomal doxorubicin and clinical outcome of HIV-1-infected patients with Kaposi's sarcoma receiving highly active antiretroviral therapy HIV Clin Trials 2 2001 429 437
88. S. Stewart, H. Jablonowski, F.D. Goebel Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group J Clin Oncol 16 1998 683 691
89. D.W. Northfelt, B.J. Dezube, J.A. Thommes Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma Results of a randomized phase III clinical trial J Clin Oncol 16 1998 2445 2451
90. R.T. Mitsuyasu, J. von Roenn, S. Krown Comparison study of liposomal doxorubicin (DOX) alone or with bleomycin and vincristine (DBV) for treatment of advanced AIDS-associated Kaposi's sarcoma (AIDS-KS) AIDS Clinical Trial Group (ACTG) protocol 286 Proc Am Soc Clin Oncol 16 1997 55a (abstr 191)
91. T. Chew, M. Jacobs, M. Huckabee A phase II clinical trial of daunorubicin citrate liposome (VS103, liposomal daunorubicin) in Kaposi's sarcoma of AIDS patients (abstr WS-BI5-3) Int Conf AIDS 9 1993 58
92. J.F. Money-Kyrle, F. Bates, J. Ready Liposomal daunorubicin in advanced Kaposi's sarcoma A phase II study Clin Oncol (R Coll Radiol) 5 1993 367 371
93. C.A. Presant, M. Scolaro, P. Kennedy Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma Lancet 341 1993 1242 1243
94. P.S. Gill, B.M. Espina, F. Muggia Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin J Clin Oncol 13 1995 996 1003
95. P.M. Girard, O. Bouchaud, A. Goetschel Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma AIDS 10 1996 753 757
96. S. Uthayakumar, M. Bower, J. Money-Kyrle Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcoma AIDS 10 1996 515 519
97. A. Tulpule, R.C. Yung, J. Wernz Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma J Clin Oncol 16 1998 3369 3374
98. P.S. Gill, J. Wernz, D.T. Scadden Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma J Clin Oncol 14 1996 2353 2364
99. D. Henry, T. Cooley, P. Volberding Final results of a phase III randomized trial of Doxil vs DaunoXome in patients with AIDS-related Kaposi's sarcoma (KS) Proc Am Soc Clin Oncol 21 2002 411a (abstr 1640)
100. D. Osoba, D.W. Northfelt, D.W. Budd Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine Cancer Invest 19 2001 573 580